Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Cost-effectiveness of chimeric antigen receptor T-cell therapy for relapsed or refractory large B-cell lymphoma: a systematic review and meta-analysis.
Journal: Journal of medical economics
Published: December 17, 2025
Nivolumab in combination with AVD as frontline treatment for patients with classic Hodgkin lymphoma: A real-world analysis from 20 US centers.
Journal: HemaSphere
Published: November 21, 2025
Treatment Outcomes and Overall Survival of Patients With B-Cell Prolymphocytic Leukemia.
Journal: EJHaem
Published: November 20, 2025
Improved screening for pulmonary Kaposi sarcoma in a low-resource setting.
Journal: AIDS (London, England)
Published: June 13, 2025
Therapeutic landscape of primary refractory and relapsed diffuse large B-cell lymphoma: Recent advances and emerging therapies.
Journal: Journal of hematology & oncology
Published: January 30, 2025
Comparison of Real-World Outcomes in Patients With Follicular Lymphoma Treated With BR Versus RCHOP-Like Regimens.
Journal: Clinical lymphoma, myeloma & leukemia
Published: January 22, 2025
Integrated genomics with refined cell-of-origin subtyping distinguishes subtype-specific mechanisms of treatment resistance and relapse in diffuse large B-cell lymphoma.
Journal: Blood cancer journal
Published: January 06, 2025
Molecular Features of Diffuse Large B-Cell Lymphoma Associated With Primary Treatment Resistance.
Journal: Hematological oncology
Published: September 05, 2024
Last Updated: 09/26/2026